RecruitingNCT06429371

Biopsychosocial Contributors to Irritability in Individuals With Shoulder Pain


Sponsor

University of Central Florida

Enrollment

60 participants

Start Date

May 24, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

Irritability was defined by Geoffrey Maitland as the vigor of activity to provoke symptoms, the severity of symptoms, and time for symptoms to subside. Irritability is deeply embedded in the physical therapy clinical decision-making process. However, the mechanisms contributing to irritability are unknown. Therefore, the purpose of this study is to characterize pain sensitivity and pain-related psychological factors by irritability level in individuals with shoulder pain.


Eligibility

Min Age: 18 YearsMax Age: 75 Years

Inclusion Criteria2

  • shoulder pain symptom intensity rated as 3/10 or higher in the past 24 hours
  • attending physical therapy for shoulder pain

Exclusion Criteria7

  • non-English speaking
  • systemic medical conditions that affect sensation, such as uncontrolled diabetes
  • history of shoulder surgery or fracture within the past 6 months
  • history of a chronic pain condition, such as fibromyalgia
  • blood clotting disorder, such as hemophilia
  • contraindication to the application of ice (blood pressure > 140/90 mmHg, cold urticaria, cryoglobulinemia, paroxysmal cold hemoglobinuria, circulatory compromise)
  • currently pregnant

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERQuantitative Sensory Testing

Participants will undergo heat pain threshold, cold pain threshold, pressure pain threshold, temporal summation, and conditioned pain modulation to characterize pain sensitivity.

OTHERPain-Related Psychological Factors

Participants will complete psychological questionnaires to characterize these factors.


Locations(1)

University of Central Florida

Orlando, Florida, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06429371


Related Trials